Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XJ0B
|
|||
| Drug Name |
Enzoxazolinone sulfonamide derivative 1
|
|||
| Synonyms |
PMID25539043-Compound-WO2013063459Example50
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
MERCK SHARP &amDOHME CORP. LAYTON, Mark, E. PERO, Joseph, E. FIJI, Hannah KELLY, Michael, J., III DE LEON, Pablo ROSSI, Michael, A. GILBERT, Kevin, F. ROECKER, Anthony, J. ZHAO, Zhijian MERCER, Swati Pal WOLKENBERG, Scott MULHEARN, James ZHAO, Lianyun LI, Dansu
|
|||
| Structure |
 |
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated sodium channel alpha Nav1.7 (SCN9A) | Target Info | Blocker | [1] |
| Target's Patent Info | Voltage-gated sodium channel alpha Nav1.7 (SCN9A) | Target's Patent Info | [1] | |
| Reactome | Interaction between L1 and Ankyrins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Sodium channel blockers: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015 Mar;25(3):279-90. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.